The effect of 1α,25(OH)2D3 vitamin over oxidative stress and biochemical parameters in rats where Type 1 diabetes is formed by streptozotocin

Journal of Diabetes and its Complications

Volumn 23, Issue 6, 2009, Pages 401-408

  Çetinkalp, Şevki ^a   Delen, Yasemin ^a   Karadeniz, Muammer ^a   Yüce, Gül ^a   Yilmaz, Candeǧer ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

1 ,25(OH)2D3 vitamin; Oxidative Stress; Streptozotocin induced diabetes

Indexed keywords

C PEPTIDE; CALCITRIOL; CATALASE; GLUCOSE; INSULIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; VITAMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CELL LEVEL; CONTROLLED STUDY; DIABETES CONTROL; ENZYME ACTIVITY; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; RAT STRAIN;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; C-PEPTIDE; CALCITRIOL; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ERYTHROCYTES; IMMUNE SYSTEM; INSULIN; MALE; OXIDATIVE STRESS; RATS; RATS, INBRED STRAINS; SUPEROXIDE DISMUTASE; VITAMINS;

EID: 70350512324     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2008.09.005     Document Type: Article

References (40)

1. Baynes J.W. Diabetes 40 (1991) 405-412
2. Baynes J.W. Role of oxidative stress in the development of complications in diabetes mellitus. Diabetes 40 (1991) 405-412
3. Baynes K.C., Boucher B.J., Feskens E.J., and Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40 3 (1997) 344-347
4. 3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production. Cellular Immunology 98 (1986) 311-322
5. 3 inhibits antigen-induced T cell activation. Journal of Immunology 133 (1984) 1748-1754
6. Bouillon R., Garmyn M., Verstuyf A., Segaert S., Casteels K., and Mathieu C. Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. European Journal of Endocrinology 133 (1995) 7-16
7. Bouillon R., Verstuyf A., Branisteanu D., Waer M., and Mathieu C. Immune modulation by vitamin D analogs in the prevention of autoimmune diseases. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 57 5 (1995) 371-385
8. 3. Curr Opin Nephrol Hypertens 4 (1995) 313-318
9. Chertow B.S., Sivitz W.I., and Baranetsky N.G. Islet insulin release and net calcium retention in vitro in vitamin D-deficient rats. Diabetes 35 7 (1986) 771-775
10. In: Cook J.D. (Ed). Measurement of iron status: a report of the International Nutritional Anemia Consultative Group (INACG) (1985), The Nutrition Foundation, Washington, DC
11. Cotran R.S., Kumar V., and Collins T. The endocrine pancreas. In: Robbins S.L. (Ed). Pathologic Basis of Disease. 6th ed. (1999), W.B. Saunders Company, Philadelphia 912-928
12. Deluca H.F., and Cantorna M.T. Vitamin D: Its role and uses in immunology. FASEB Journal 15 (2001) 2579-2585
13. Eisenbarth G.S., Zi{dotless}egler A.G., and Colman P.A. Pathogenesis of insulin dependent diabetes mellitus. In: Kahn R., and Weir G.C. (Eds). Joslin's Diabetes Mellitus. 13th ed. (1994), Lippincott Williams and Wilkins, Philadelphia 216-240
14. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Diabetes 52 (2003) 1-8
15. Gedik O., and Akali{dotless}n S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29 (1986) 142-145
16. Gillery P., Monboisse J.C., Maquart F.X., and Borel J.P. Diabetes & Metabolism 14 (1998) 25-30
17. Giugliano D., Ceriello A., and Poalisso G. Diabetes mellitus, hypertension, and cardiovascular disease: Which role for oxidative stress?. Metabolism 44 (1995) 363-368
18. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., and Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 358 (2001) 1500-1503
19. 3 on insulin secretion in diabetes mellitus. Bone and Miner 1 3 (1986) 187-192
20. Ishi{dotless}da H., Seino Y., Tsuda K., et al. Effects of streptozotocin-induced diabetes on circulating levels of vitamin D metabolites. Acta Endocrinologica 104 1 (1983) 96-102
21. 3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 34 4 (1985) 315-320
22. Karasi{dotless}k A., and Hattori M. Use of animal models in the study of diabetes. In: Weir G.C., and Khan R. (Eds). Joslin's Diabetes Mellitus. 13th ed. (1994), Lippincott Williams and Wilkins, Philadelphia 317-350
23. 3 and the immune system. Molecular and Cellular Endocrinology 43 (1985) 113-122
24. 3 analogs as immunomodulatory agents. Trends in Molecular Medicine 8 (2002) 174-179
25. Mathieu C., Laureys J., Waer M., and Bouillon R. Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: Synergy with cyclosporine. Transplantation Proceedings 26 6 (1994) 3128-3129
26. Mauricio D., Mandrup-Poulsen T., and Nerup J. Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: A therapeutic perspective. Diabetes/Metabolism Reviews 12 1 (1996) 57-68
27. Merlino L., Curtis J., Mikuls T.R., Cerhan J.R., Criswell L.A., and Saag K.G. Vitamin D intake is inversely associated with rheumatoid arthritis. Results from the Iowa Women's Health Study. Arthritis and Rheumatism 50 (2004) 72-77
28. 3. Immunology Letters 28 (1991) 115-120
29. Patel S.R., Xu Y., Koenig R.J., and Hsu C.H. Effect of glucose on the function of the calcitriol receptor and vitamin D metabolism. Kidney International 52 1 (1997) 79-86
30. Sakai K., Matsumoto K., Nishikawa T., Suefuji M., Nakamaru K., Hirashima Y., et al. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochemical and Biophysical Research Communications 300 (2003) 216-222
31. Schneider L.E., Schedl H.P., McCain T., and Haussler M.R. Experimental diabetes reduces circulating 1,25-dihidroksivitamin D in the rat. Science 196 (1977) 1452-1454
32. Sena C.M., Nunes E., Louro T., Proenca T., and Seica R.M. Endothelial dysfunction in type 2 diabetes: Effect of antioxidants. Revista Portuguesa de Cardiologia 26 6 (2007) 609-619
33. Shafrir E. Diabetes in animals. In: Porte D., and Sherwin R.S. (Eds). Ellenberg & Rifkin's Diabetes Mellitus (1997), Appleton and Lange, New York 301-348 chapter 18
34. Sozmen E.Y., Sozmen B., Girgin F.K., Delen Y., Azarsi{dotless}z E., Erdener D., and Ersöz B. Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation. Clinical and Experimental Medicine 1 (2001) 195-199
35. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206 (1979) 1188-1190
36. Tesfamariam B., and Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. American Journal of Physiology 263 (1992) 321-326
37. The EORODIAB Substudy Group. Vitamin D supplement in early childhood and risk for Type 1 diabetes mellitus. Diabetologia 42 1 (1999) 51-54
38. Thomasset M. Vitamin D and immune system. Pathologie-biologie 42 2 (1994) 163-172
39. Westermar P. Pathology of the pancreas in diabetes mellitus. In: Porte D., and Sherwin R.S. (Eds). Ellenberg & Rifkin's Diabetes Mellitus (1997), Appleton and Lange, New York 349-355 chapter 19
40. Wolf S.P. Diabetes mellitus and free radicals. British Medical Bulletin 49 (1993) 642-652